Emily M. Eshleman

931 total citations · 1 hit paper
21 papers, 626 citations indexed

About

Emily M. Eshleman is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Emily M. Eshleman has authored 21 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Emily M. Eshleman's work include Gut microbiota and health (8 papers), IL-33, ST2, and ILC Pathways (6 papers) and Immune Cell Function and Interaction (6 papers). Emily M. Eshleman is often cited by papers focused on Gut microbiota and health (8 papers), IL-33, ST2, and ILC Pathways (6 papers) and Immune Cell Function and Interaction (6 papers). Emily M. Eshleman collaborates with scholars based in United States, Canada and Austria. Emily M. Eshleman's co-authors include Theresa Alenghat, Vivienne Woo, Laurel Lenz, Laura Engleman, Jordan Whitt, David Haslam, Seika Hashimoto‐Hill, Rebekah Karns, Shu-en Wu and Lee A. Denson and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

Emily M. Eshleman

21 papers receiving 619 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity

2024 63 citations Emily M. Eshleman, Taylor Rice et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily M. Eshleman United States	14	314	173	101	100	69	21	626
Iris Stolzer Germany	11	324 1.0×	124 0.7×	91 0.9×	58 0.6×	46 0.7×	16	529
Maureen J. Ostaff Germany	9	330 1.1×	123 0.7×	126 1.2×	106 1.1×	39 0.6×	11	648
Krystal L. Ching United States	5	482 1.5×	245 1.4×	64 0.6×	73 0.7×	68 1.0×	6	744
Alexi A. Schoenborn United States	11	462 1.5×	215 1.2×	124 1.2×	128 1.3×	50 0.7×	17	750
Xin Wen China	15	184 0.6×	104 0.6×	54 0.5×	105 1.1×	54 0.8×	33	547
Tilman E. Klassert Germany	19	269 0.9×	172 1.0×	53 0.5×	156 1.6×	81 1.2×	45	728
Taylor K. Farley United States	6	260 0.8×	200 1.2×	58 0.6×	46 0.5×	46 0.7×	8	543
David Prescott Canada	14	445 1.4×	261 1.5×	133 1.3×	114 1.1×	58 0.8×	21	811
Masato Tsuda Japan	14	443 1.4×	208 1.2×	127 1.3×	49 0.5×	40 0.6×	26	741

Countries citing papers authored by Emily M. Eshleman

Since Specialization

Citations

This map shows the geographic impact of Emily M. Eshleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. Eshleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. Eshleman more than expected).

Fields of papers citing papers by Emily M. Eshleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily M. Eshleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. Eshleman. The network helps show where Emily M. Eshleman may publish in the future.

Co-authorship network of co-authors of Emily M. Eshleman

This figure shows the co-authorship network connecting the top 25 collaborators of Emily M. Eshleman. A scholar is included among the top collaborators of Emily M. Eshleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily M. Eshleman. Emily M. Eshleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kinder, Jeremy M., Jerilyn K. Gray, Tzu‐Yu Shao, et al.. (2025). Microbiota-derived inosine programs protective CD8+ T cell responses against influenza in newborns. Cell. 188(16). 4239–4256.e19. 2 indexed citations

Eshleman, Emily M., Taylor Rice, Crystal Potter, et al.. (2024). Microbiota-derived butyrate restricts tuft cell differentiation via histone deacetylase 3 to modulate intestinal type 2 immunity. Immunity. 57(2). 319–332.e6. 63 indexed citations breakdown →

Eshleman, Emily M., et al.. (2024). Epithelial regulation of microbiota-immune cell dynamics. Mucosal Immunology. 17(2). 303–313. 14 indexed citations

Eshleman, Emily M., Viral G. Jain, David Haslam, et al.. (2023). IEC-intrinsic IL-1R signaling holds dual roles in regulating intestinal homeostasis and inflammation. The Journal of Experimental Medicine. 220(6). 13 indexed citations

Eshleman, Emily M., Tzu‐Yu Shao, Vivienne Woo, et al.. (2023). Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity. Journal of Clinical Investigation. 133(4). 34 indexed citations

Shao, Tzu‐Yu, Tony T. Jiang, Abigail E. Russi, et al.. (2023). Kruppel-like factor 2+ CD4 T cells avert microbiota-induced intestinal inflammation. Cell Reports. 42(11). 113323–113323. 1 indexed citations

Waddell, Amanda, Neha R. Santucci, Nicholas J. Ollberding, et al.. (2023). Microbiota‐derived butyrate dampens linaclotide stimulation of the guanylate cyclase C pathway in patient‐derived colonoids. Neurogastroenterology & Motility. 35(12). e14681–e14681. 2 indexed citations

Eshleman, Emily M., Taylor Rice, Crystal Potter, et al.. (2023). Microbiota dampen type 2 immunity by epigenetically restricting tuft cell differentiation. The Journal of Immunology. 210(Supplement_1). 150.08–150.08. 1 indexed citations

Moutinho, Thomas J., Paul Mitchell, Ajay Kumar, et al.. (2022). Histone Deacetylase Inhibition by Gut Microbe-Generated Short-Chain Fatty Acids Entrains Intestinal Epithelial Circadian Rhythms. Gastroenterology. 163(5). 1377–1390.e11. 77 indexed citations

10.

Woo, Vivienne, Emily M. Eshleman, Seika Hashimoto‐Hill, et al.. (2021). Commensal segmented filamentous bacteria-derived retinoic acid primes host defense to intestinal infection. Cell Host & Microbe. 29(12). 1744–1756.e5. 66 indexed citations

11.

Eshleman, Emily M. & Theresa Alenghat. (2021). Epithelial sensing of microbiota-derived signals. Genes and Immunity. 22(5-6). 237–246. 14 indexed citations

12.

Eshleman, Emily M., et al.. (2020). Myeloid cell responsiveness to interferon-gamma is sufficient for initial resistance to Listeria monocytogenes. SHILAP Revista de lepidopterología. 1. 1–9. 3 indexed citations

13.

Wu, Shu-en, Seika Hashimoto‐Hill, Vivienne Woo, et al.. (2020). Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature. 586(7827). 108–112. 164 indexed citations

14.

Eshleman, Emily M., et al.. (2020). Epithelial cell intrinsic IL-1R signaling regulates intestinal homeostasis and inflammation. The Journal of Immunology. 204(1_Supplement). 235.6–235.6. 1 indexed citations

15.

Woo, Vivienne, Emily M. Eshleman, Taylor Rice, et al.. (2019). Microbiota Inhibit Epithelial Pathogen Adherence by Epigenetically Regulating C-Type Lectin Expression. Frontiers in Immunology. 10. 928–928. 19 indexed citations

16.

Eshleman, Emily M., et al.. (2017). Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection. PLoS Pathogens. 13(5). e1006388–e1006388. 21 indexed citations

17.

Eshleman, Emily M. & Laurel Lenz. (2014). Type I Interferons in Bacterial Infections: Taming of Myeloid Cells and Possible Implications for Autoimmunity. Frontiers in Immunology. 5. 431–431. 34 indexed citations

18.

Eshleman, Emily M., et al.. (2013). Type I IFNs Downregulate Myeloid Cell IFN-γ Receptor by Inducing Recruitment of an Early Growth Response 3/NGFI-A Binding Protein 1 Complex That Silences ifngr1 Transcription. The Journal of Immunology. 191(6). 3384–3392. 39 indexed citations

19.

Birlea, Marius, Gregory P. Owens, Emily M. Eshleman, et al.. (2012). Human Anti-Varicella-Zoster Virus (VZV) Recombinant Monoclonal Antibody Produced after Zostavax Immunization Recognizes the gH/gL Complex and Neutralizes VZV Infection. Journal of Virology. 87(1). 415–421. 14 indexed citations

20.

Eshleman, Emily M., Aamir Shahzad, & Randall J. Cohrs. (2011). Varicella Zoster Virus Latency. Future Virology. 6(3). 341–355. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact